We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current FOLD market cap is 2.85B. The company's latest EPS is USD -0.5132 and P/E is -18.82.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 86.27M | 94.5M | 103.5M | 115.08M | 110.4M |
| Operating Income | -37.64M | -17.39M | -15.03M | -3.69M | -27.72M |
| Net Income | -52.93M | -43.23M | -21.58M | -33.84M | -48.42M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 182.24M | 260.89M | 305.51M | 329.23M | 399.36M |
| Operating Income | -304.04M | -247M | -206.43M | -204.43M | -73.49M |
| Net Income | -356.39M | -276.85M | -250.46M | -236.57M | -151.58M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 700.52M | 730.09M | 764.08M | 777.88M | 721.79M |
| Total Liabilities | 597.95M | 618.51M | 630.85M | 617.71M | 591.1M |
| Total Equity | 102.57M | 111.58M | 133.24M | 160.17M | 130.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 850.21M | 886.52M | 905.14M | 724.17M | 777.88M |
| Total Liabilities | 373.78M | 600.14M | 597.77M | 601.12M | 617.71M |
| Total Equity | 476.43M | 286.38M | 307.37M | 123.05M | 160.17M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.07M | -34.2M | -72.55M | -69.09M | -29.7M |
| Investing | 36.26M | 86.26M | 122.02M | 98.06M | 7.54M |
| Financing | -7.83M | 15.85M | 53.47M | 61.68M | -13.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -250.42M | -233.29M | -202.49M | -166.58M | -69.09M |
| Investing | 95.15M | -13.58M | 78.76M | 92.32M | 98.06M |
| Financing | 217.5M | 262.86M | 212.07M | -7.46M | 61.68M |
| Market Cap | 2.85B |
| Price to Earnings Ratio | -18.82 |
| Price to Sales Ratio | 7.14 |
| Price to Cash Ratio | 11.55 |
| Price to Book Ratio | 17.81 |
| Dividend Yield | - |
| Shares Outstanding | 295.38M |
| Average Volume (1 week) | 2.25M |
| Average Volume (1 Month) | 2.65M |
| 52 Week Change | -17.22% |
| 52 Week High | 14.57 |
| 52 Week Low | 9.02 |
| Spread (Intraday) | 0.73 (7.43%) |
| Company Name | Amicus Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.amicusrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
